Chimera Investment Corporation
NYSE:CIMREIT - Mortgage
+$0.12 today
- Market cap
- $541.62M
- Beta
- 1.76
- P/E (TTM)
- 58.1
- EPS (TTM)
- $0.23
- Dividend yield
- 11.65%
Volume 1.98M
Average 0.70M
CIM EBITDA Margin
EBITDA as a percentage of revenue.
Chimera Investment CorporationNYSE: CIM
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to -19.3%
EBITDA Margin was -19.3% in Q1 FY2026, down 72.7 pp from a year earlier. On a trailing-twelve-month basis it was 50.9%, down 86.5 pp year over year. Over 3 fiscal years it widened by 68.3 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 2 analysts of 47.1% for the fiscal year ending Dec 2026, down from 96.8% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -19.3%-108.5 pp QoQ
- Last fiscal yearDec 2025
- 96.8%-164.0 pp YoY
- LTMMar 2026
- 50.9%-86.5 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -72.7 pp | -223.2 pp | -150.5 pp |
| 1 year | -164.0 pp | -49.7 pp | +114.2 pp |
| 3 years | +68.3 pp | -47.2 pp | -115.5 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 96.8%
- Year-over-year change
- -164.0pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 96.8% | -164.0pp |
| FY2024 | 2024-12-31 | 260.8% | -49.7pp |
| FY2023 | 2023-12-31 | 310.5% | +281.9pp |
| FY2022 | 2022-12-31 | 28.5% | -72.8pp |
| FY2021 | 2021-12-31 | 101.4% | — |
EBITDA Margin vs competitors
How CIM compares with its peers on the latest reported figures
- CIM's LTM Mar 2026 EBITDA Margin of 50.9% is the 6th highest of the 9 companies compared; the peer median is 63.2%.
- Its year-over-year change of -86.5 pp is the 6th highest of 9, against a peer median of -45.2 pp.
- Over three fiscal years its change of +68.3 pp compares with a peer median of +45.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 137.8% | -400.7 pp | +258.9 pp | |
| LTM Jun 2026 | 86.7% | +17.4 pp | +63.5 pp | |
| LTM Mar 2026 | 72.9% | -106.5 pp | -78.1 pp | |
| LTM Sep 2026 | 65.4% | -25.1 pp | +28.3 pp | |
| LTM Mar 2026 | 61.0% | -2.1 pp | +18.8 pp | |
| LTM Mar 2026 | 50.9% | -86.5 pp | +68.3 pp | |
| LTM Sep 2026 | 47.5% | -150.1 pp | +262.3 pp | |
| LTM Mar 2026 | 29.9% | +29.9 pp | +78.8 pp | |
| LTM Mar 2026 | 16.9% | -65.3 pp | -4616.1 pp | |
| Peer median (excluding CIM) | 63.2% | -45.2 pp | +45.9 pp | |
Competitors are the stored peer set for CIM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.06B | (415.21M) | 204.77M | 257.93M | 820.77M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 42.1M |
| Gross Profit | 1.06B | (415.21M) | 204.77M | 257.93M | 778.67M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 94.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 69.07M | 72.03M | 55.69M | 64.57M | 30M |
| Operating Expenses | 1.06B | (415.21M) | 204.77M | 257.93M | 14.01M |
| Depreciation & Amortization | 70.58M | 61.49M | 0 | 321K | 7.18M |
| EBITDA | 1.07B | (118.54M) | 635.75M | 672.71M | 794.87M |
| EBITDA Margin | 101.4% | 28.5% | 310.5% | 260.8% | 96.8% |
| Operating Income | 0 | 0 | 0 | 0 | 764.65M |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 93.2% |
| Interest Income | 937.55M | 773.12M | 772.9M | 760.95M | 821.86M |
| Interest Expense | 326.63M | 333.29M | 509.54M | 496.27M | 554.92M |
| Other Income / Expenses | 674.52M | (513.32M) | 126.21M | 176.11M | (531.89M) |
| Income Before Tax | 674.52M | (513.32M) | 126.21M | 176.11M | 232.77M |
| Pre-Tax Margin | 63.8% | 123.6% | 61.6% | 68.3% | 28.4% |
| Income Tax Expense | 4.41M | (253K) | 102K | 49K | 2.27M |
| Net Income | 670.11M | (513.07M) | 126.1M | 176.07M | 230.5M |
| Net Margin | 63.4% | 123.6% | 61.6% | 68.3% | 28.1% |
| EPS (Basic) | 7.65 | (2.19) | 0.55 | 1.12 | 2.80 |
| EPS (Diluted) | 2.43 | (2.19) | 0.54 | 1.10 | 2.75 |
| Weighted Avg Shares | 77.92M | 77.98M | 76.64M | 80.99M | 82.18M |
| Weighted Avg Shares (Diluted) | 81.83M | 77.98M | 78.14M | 82.16M | 83.94M |
Chimera Investment Corporation
NYSE:CIM
Intrinsic Alpha fair value
Locked
Current Price
$6.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.